Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06513676Recruiting
Adrenal artery treatment for aldosteronism study
This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.
Ürümqi, XinjiangAges 18–60 - NCT06515106Recruiting
Living with LGI1 encephalitis: a study on long-term symptoms
This study looks at symptoms, biomarkers, and mechanisms of the chronic phase of LGI1 antibody-mediated encephalitis. It aims to understand what happens after the acute stage and how to better manage long-term effects.
Barcelona, CataloniaAges Any age - NCT06517004RecruitingPhase 1
Study of JWCAR201 for relapsed or refractory large B-cell lymphoma
This trial tests a new cell therapy called JWCAR201 for people with a type of lymphoma (diffuse large B-cell lymphoma) that has come back or not responded to at least two prior treatments. The goal is to see if this treatment can help when standard options have stopped working.
ShanghaiAges 18 years+ - NCT05219903Recruiting
Study of children with eosinophilic gut disorders
This study looks at children ages 0–18 with eosinophilic gut disorders (EGIDs) to better understand these conditions and how they are managed. It may help doctors improve care by comparing real-world information from patients followed at participating hospitals.
PaviaAges birth–18 years - NCT06462742Recruiting
Microwave ablation vs. surgery for intrahepatic cholangiocarcinoma
This trial compares two treatments for a liver cancer called intrahepatic cholangiocarcinoma—surgery to remove the tumor versus microwave ablation, which uses heat to destroy cancer cells. It tests if ablation works as well as surgery for people with small tumors that haven't spread.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06518434RecruitingPhase 2
Cannabis oil for advanced liver cancer study
This study tests if cannabis oil can help people with advanced liver cancer that cannot be treated with standard therapies. It is a small pilot study to see if the oil is safe and may improve symptoms or quality of life.
GroningenAges 18 years+ - NCT07794839Recruiting
Drug-coated balloon treatment for heart artery blockages
This trial tests a special balloon that releases medicine to open blocked heart arteries. It may help people with chest pain or silent ischemia by keeping arteries open longer.
IstanbulAges Any age - NCT06512493Recruiting
South East Netherlands Heart Registry
This is a heart registry that collects information from all patients to get a complete picture of heart care in the region. By including everyone, it aims to improve future treatments without bias.
Heerlen, LimburgAges Any age - NCT07794150RecruitingPhase 1
Skin response study of an estradiol and levonorgestrel patch in healthy postmenopausal women
This study tests a new skin patch that releases two hormones (estradiol and levonorgestrel) to see how it affects the skin. It is for healthy postmenopausal women and checks for any irritation or allergic reactions.
Las Vegas, NevadaAges 40–75 - NCT07799870Recruiting
Checking vital signs in newborns with Lifelight software
This study tests a new camera-based software called Lifelight to measure vital signs like heart rate and breathing in newborns in the neonatal intensive care unit (NICU), compared to the usual monitors. It may offer a less intrusive way to monitor your baby.
London, LondonAges birth–1 year - NCT07795814RecruitingPhase 2
Study of a new medicine for heart failure with preserved pumping function
This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.
Birmingham, AlabamaAges 30–84 - NCT07796230Recruiting
Testing a new eye camera for people with retinal conditions
This study is testing a new camera system to take pictures of the inside of the eye (the back part where the retina is). It is for people who have eye diseases like age-related macular degeneration, glaucoma, or diabetic retinopathy. The goal is to see how well the camera works in real-world conditions.
Louisville, KentuckyAges 22 years+ - NCT07798648RecruitingPhase 3
COVID-19 vaccine study for children and adults
This study tests a COVID-19 vaccine in children and adults. It may help protect against COVID-19.
Homestead, FloridaAges 5 years+ - NCT07793019RecruitingPhase 1
Weight loss and safety study in overweight adults
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Beijing, Beijing MunicipalityAges 18–55 - NCT07794891RecruitingPhase 4
Botox for jawline and neck lines
This study tests a cosmetic treatment using Botox to improve the appearance of neck lines and jawline definition. It aims to see how satisfied participants are with the results after treatment.
Vancouver, British ColumbiaAges 22–65 - NCT07796659Recruiting
Early study of a new implant for leaking heart valve
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
TbilisiAges 18 years+ - NCT07794592RecruitingPhase 1
Comparing two ways of taking olomorasib in healthy volunteers
This study tests a new medicine called olomorasib in healthy volunteers to see how it works in the body depending on how it's taken. The goal is to find a better, safer way to give this medicine for future patients.
Daytona Beach, FloridaAges 18–55 - NCT07800871RecruitingPhase 1/Phase 2
FT839 cell therapy for autoimmune diseases
This trial tests a new cell therapy (FT839) designed to target and reset the immune system's B cells to help treat moderate to severe autoimmune diseases that haven't improved with standard treatments. It's an early-phase study, so the main goals are to see if it's safe and if it helps control the disease.
Fullerton, CaliforniaAges 18–70 - NCT07800104RecruitingPhase 1
Study of a new pill for moderate-to-severe eczema
This trial tests an experimental medicine called QX-4533. The study has two parts: one tests the drug in healthy volunteers, and the other tests it in people with moderate-to-severe atopic dermatitis (a type of eczema) that hasn't responded well to standard creams. The goal is to see if the drug is safe and how well it works.
Shanghai, Shanghai MunicipalityAges 1.5 years–65 years - NCT07799688RecruitingPhase 2
Study of a new drug for high triglycerides
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
Jinan, ShandongAges 18–79 - NCT07800897RecruitingPhase 1
How a new drug reacts with food and other medicines in healthy women
This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.
Québec, QuebecAges 18–55 - NCT07795164RecruitingPhase 3
Study of pemvidutide for liver scarring from MASH
This study tests an investigational medicine called pemvidutide to see if it can reduce liver scarring in people with MASH (a liver condition linked to excess weight and metabolic issues). It may help improve liver health and potentially slow or reverse the condition.
North Little Rock, ArkansasAges 18–75 - NCT07798427Enrolling by invitation
Ultrasound-guided IV placement study
This study compares two ways to place an IV (a small tube that gives you medicine or fluids through a vein). One method uses ultrasound to find the best vein, the other uses the traditional method. It aims to see if ultrasound helps make IV placement easier and more successful.
New York, New YorkAges 12 years+ - NCT06519552RecruitingPhase 1
Gene therapy study for adults with MPS type I
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
Chengdu, SichuanAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.